Peter A. Kadens - 12 Jun 2025 Form 4 Insider Report for NewLake Capital Partners, Inc. (NLCP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jun 2025, 13:44:47 UTC
Prior SEC filing
15 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa Meyer, attorney in fact

Key filing fact

Peter A. Kadens filed Form 4 for NewLake Capital Partners, Inc. (NLCP) on 13 Jun 2025.

Key facts

  • This page summarizes Peter A. Kadens's Form 4 filing for NewLake Capital Partners, Inc. (NLCP).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Jun 2025, 13:44.

Change

  • Previous filing in this sequence was filed on 15 Apr 2025.
  • Current net transaction value: -$5,361.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001813982 Primary reporting owner

Kadens Peter A.

Relationship
Director
Address
C/O NEWLAKE CAPITAL PARTNERS, INC., 50 LOCUST AVENUE, FIRST FLOOR, NEW CANAAN
Signature
/s/ Lisa Meyer, attorney in fact
Signature date
13 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NLCP holding

Common Stock, par value $0.01 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
111,408
Date
12 Jun 2025
Ownership
Direct
NLCP holding

Common Stock, par value $0.01 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,462
Date
12 Jun 2025
Ownership
See footnote
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NLCP transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
$0
Shares
+360
Change %
Price
$0.000000
Shares after
360
Date
12 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
360
Exercise price
Footnotes
F2
NLCP transaction Derivative

Dividend Equivalent Rights

Disposed to Issuer

Transaction value
$5,361
Shares
-360
Change %
-100%
Price
$14.90
Shares after
0
Date
12 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
360
Exercise price
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Peter A. Kadens is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Held by AK Investment One LLC beneficially owned by Amy Kadens, spouse of the Reporting Person, by virtue of her sole voting power over the shares.

Footnote F2

Dividend equivalent rights accrued with respect to these RSUs when and as dividends were paid on the Issuer's common stock. The dividend equivalent rights were settled in cash on June 12, 2025, in accordance with the terms of the 2021 Equity Incentive Plan, subsequent to the vesting of the underlying RSUs on June 5, 2025. The number of shares of common stock underlying the dividend equivalent rights were determined by dividing the dollar amount of the accrued dividend equivalent rights by $14.90, which was the closing price of the Issuer's common stock on June 12, 2025.

SEC remarks

The Reporting Person retired from the Board of Directors on June 5, 2025 at the expiration of his term.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .